Novo Nordisk shares jump 8% on promising weight loss trial results; Eli Lilly dips
Novo Nordisk shares climbed 8% on Thursday after the Danish pharmaceutical giant reported positive early trial data for a new weight loss drug.
Novo Nordisk shares climbed 8% on Thursday after the Danish pharmaceutical giant reported positive early trial data for a new weight loss drug.
